Drug
Naldemedine
Naldemedine: highest development phase Phase 3, developed by Shionogi. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Shionogi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Naldemedine NCT01965652 | Phase 3 | Opioid-induced Constipation |
| Naldemedine NCT01443403 | Phase 2 | Opioid-induced Constipation |
| Naldemedine NCT05588323 | Phase 1/2 | Opioid-Induced Constipation (OIC) |
Latest
No recent events.
Follow Naldemedine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.